Pharmaceutical Industry Warned of Tariff Threats

Sandoz CEO Richard Saynor warned that steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply, impacting the pharmaceutical industry. The threat comes as tensions in trade relations continue to rise.